Cancer survival analysis on population-based cancer registry data in Zhejiang Province, China (2018–2019)
Objective: This is a comprehensive overview of long-term cancer survival in Zhejiang Province, China. Hybrid analysis, a combination of cohort and period analysis, has been proposed to derive up-to-date cancer survival estimates. Using this approach, we aimed to timely and accurately analyze the 5-y...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-03-01
|
| Series: | Journal of the National Cancer Center |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667005423000856 |
| _version_ | 1797233949522526208 |
|---|---|
| author | Huizhang Li Youqing Wang Weiwei Gong Chen Zhu Le Wang Yaoyao Chen Lingbin Du Xiangdong Cheng |
| author_facet | Huizhang Li Youqing Wang Weiwei Gong Chen Zhu Le Wang Yaoyao Chen Lingbin Du Xiangdong Cheng |
| author_sort | Huizhang Li |
| collection | DOAJ |
| description | Objective: This is a comprehensive overview of long-term cancer survival in Zhejiang Province, China. Hybrid analysis, a combination of cohort and period analysis, has been proposed to derive up-to-date cancer survival estimates. Using this approach, we aimed to timely and accurately analyze the 5-year relative survival (RS) and net survival (NS) in cancer registries of Zhejiang Province, China. Methods: A total of 255,725 new cancer cases diagnosed during 2013–2017 were included in 14 cancer registries in Zhejiang Province, China, with a follow-up on vital status until the end of 2019. The hybrid analysis was used to calculate the 5-year RS and 5-year NS during 2018–2019 for overall and stratifications by sex, cancer type, region, and age at diagnosis. Results: During 2018–2019, the age-standardized 5-year RS and NS for overall cancer in Zhejiang was 47.5% and 48.6%, respectively. The age-standardized 5-year RS for cancers of women (55.4%) was higher than that of men (40.0%), and the rate of urban areas (49.7%) was higher than that of rural areas (43.1%). The 5-year RS declined along with age, from 84.4% for ages <45 years to 23.7% for ages >74 years. Our results of the RS and NS showed the similar trend and no significant difference. The top five cancers with top age-standardized 5-year RS were thyroid cancer (96.0%), breast cancer (84.3%), testicular cancer (79.9%), prostate cancer (77.2%), and bladder cancer (70.6%), and the five cancers with the lowest age-standardized 5-year RS were pancreatic cancer (6.0%), liver cancer (15.6%), gallbladder cancer (17.1%), esophageal cancer (22.7%), and leukemia (31.0%). Conclusions: We reported the most up-to-date 5-year cancer RS and NS in Zhejiang Province, China for the first time, and found that the 5-year survival for cancer patients in Zhejiang during 2018–2019 was relatively high. The population-based cancer registries are recognized as key policy tools that can be used to evaluate both the impact of cancer prevention strategies and the effectiveness of health systems. |
| first_indexed | 2024-04-24T16:24:18Z |
| format | Article |
| id | doaj.art-1a177d59ca8442438c6715557da821c9 |
| institution | Directory Open Access Journal |
| issn | 2667-0054 |
| language | English |
| last_indexed | 2024-04-24T16:24:18Z |
| publishDate | 2024-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of the National Cancer Center |
| spelling | doaj.art-1a177d59ca8442438c6715557da821c92024-03-31T04:38:07ZengElsevierJournal of the National Cancer Center2667-00542024-03-01415462Cancer survival analysis on population-based cancer registry data in Zhejiang Province, China (2018–2019)Huizhang Li0Youqing Wang1Weiwei Gong2Chen Zhu3Le Wang4Yaoyao Chen5Lingbin Du6Xiangdong Cheng7Department of Cancer Prevention/Zhejiang Provincial Office for Cancer Prevention and Control, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, ChinaDepartment of Cancer Prevention/Zhejiang Provincial Office for Cancer Prevention and Control, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, ChinaDepartment of Chronic Non-communicable Disease Prevention and Control, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, ChinaDepartment of Cancer Prevention/Zhejiang Provincial Office for Cancer Prevention and Control, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, ChinaDepartment of Cancer Prevention/Zhejiang Provincial Office for Cancer Prevention and Control, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, ChinaDepartment of Cancer Prevention/Zhejiang Provincial Office for Cancer Prevention and Control, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, ChinaDepartment of Cancer Prevention/Zhejiang Provincial Office for Cancer Prevention and Control, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China; Corresponding authors.Department of Gastric Surgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China; Corresponding authors.Objective: This is a comprehensive overview of long-term cancer survival in Zhejiang Province, China. Hybrid analysis, a combination of cohort and period analysis, has been proposed to derive up-to-date cancer survival estimates. Using this approach, we aimed to timely and accurately analyze the 5-year relative survival (RS) and net survival (NS) in cancer registries of Zhejiang Province, China. Methods: A total of 255,725 new cancer cases diagnosed during 2013–2017 were included in 14 cancer registries in Zhejiang Province, China, with a follow-up on vital status until the end of 2019. The hybrid analysis was used to calculate the 5-year RS and 5-year NS during 2018–2019 for overall and stratifications by sex, cancer type, region, and age at diagnosis. Results: During 2018–2019, the age-standardized 5-year RS and NS for overall cancer in Zhejiang was 47.5% and 48.6%, respectively. The age-standardized 5-year RS for cancers of women (55.4%) was higher than that of men (40.0%), and the rate of urban areas (49.7%) was higher than that of rural areas (43.1%). The 5-year RS declined along with age, from 84.4% for ages <45 years to 23.7% for ages >74 years. Our results of the RS and NS showed the similar trend and no significant difference. The top five cancers with top age-standardized 5-year RS were thyroid cancer (96.0%), breast cancer (84.3%), testicular cancer (79.9%), prostate cancer (77.2%), and bladder cancer (70.6%), and the five cancers with the lowest age-standardized 5-year RS were pancreatic cancer (6.0%), liver cancer (15.6%), gallbladder cancer (17.1%), esophageal cancer (22.7%), and leukemia (31.0%). Conclusions: We reported the most up-to-date 5-year cancer RS and NS in Zhejiang Province, China for the first time, and found that the 5-year survival for cancer patients in Zhejiang during 2018–2019 was relatively high. The population-based cancer registries are recognized as key policy tools that can be used to evaluate both the impact of cancer prevention strategies and the effectiveness of health systems.http://www.sciencedirect.com/science/article/pii/S2667005423000856Cancer registryCancer survivalHybrid analysisRelative survivalNet survival |
| spellingShingle | Huizhang Li Youqing Wang Weiwei Gong Chen Zhu Le Wang Yaoyao Chen Lingbin Du Xiangdong Cheng Cancer survival analysis on population-based cancer registry data in Zhejiang Province, China (2018–2019) Journal of the National Cancer Center Cancer registry Cancer survival Hybrid analysis Relative survival Net survival |
| title | Cancer survival analysis on population-based cancer registry data in Zhejiang Province, China (2018–2019) |
| title_full | Cancer survival analysis on population-based cancer registry data in Zhejiang Province, China (2018–2019) |
| title_fullStr | Cancer survival analysis on population-based cancer registry data in Zhejiang Province, China (2018–2019) |
| title_full_unstemmed | Cancer survival analysis on population-based cancer registry data in Zhejiang Province, China (2018–2019) |
| title_short | Cancer survival analysis on population-based cancer registry data in Zhejiang Province, China (2018–2019) |
| title_sort | cancer survival analysis on population based cancer registry data in zhejiang province china 2018 2019 |
| topic | Cancer registry Cancer survival Hybrid analysis Relative survival Net survival |
| url | http://www.sciencedirect.com/science/article/pii/S2667005423000856 |
| work_keys_str_mv | AT huizhangli cancersurvivalanalysisonpopulationbasedcancerregistrydatainzhejiangprovincechina20182019 AT youqingwang cancersurvivalanalysisonpopulationbasedcancerregistrydatainzhejiangprovincechina20182019 AT weiweigong cancersurvivalanalysisonpopulationbasedcancerregistrydatainzhejiangprovincechina20182019 AT chenzhu cancersurvivalanalysisonpopulationbasedcancerregistrydatainzhejiangprovincechina20182019 AT lewang cancersurvivalanalysisonpopulationbasedcancerregistrydatainzhejiangprovincechina20182019 AT yaoyaochen cancersurvivalanalysisonpopulationbasedcancerregistrydatainzhejiangprovincechina20182019 AT lingbindu cancersurvivalanalysisonpopulationbasedcancerregistrydatainzhejiangprovincechina20182019 AT xiangdongcheng cancersurvivalanalysisonpopulationbasedcancerregistrydatainzhejiangprovincechina20182019 |